{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:36:26Z","timestamp":1790116586737,"version":"4.0.1"},"reference-count":35,"publisher":"Harborside Press, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Pancreatic adenocarcinoma (PC) is a highly lethal malignancy with a survival rate of only 12%. Surveillance is recommended for high-risk individuals (HRIs), but it is not widely adopted. To address this unmet clinical need and drive early diagnosis research, we established the Pancreatic Cancer Early Detection (PRECEDE) Consortium.\n                    <jats:bold>Methods:<\/jats:bold>\n                    PRECEDE is a multi-institutional international collaboration that has undertaken an observational prospective cohort study. Individuals (aged 18\u201390 years) are enrolled into 1 of 7 cohorts based on family history and pathogenic germline variant (PGV) status. From April 1, 2020, to November 21, 2022, a total of 3,402 participants were enrolled in 1 of 7 study cohorts, with 1,759 (51.7%) meeting criteria for the highest-risk cohort (Cohort 1). Cohort 1 HRIs underwent germline testing and pancreas imaging by MRI\/MR-cholangiopancreatography or endoscopic ultrasound.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 1,400 participants in Cohort 1 (79.6%) had completed baseline imaging and were subclassified into 3 groups based on familial PC (FPC; n=670), a PGV and FPC (PGV+\/FPC+; n=115), and a PGV with a pedigree that does not meet FPC criteria (PGV+\/FPC\u2013; n=615). One HRI was diagnosed with stage IIB PC on study entry, and 35.1% of HRIs harbored pancreatic cysts. Increasing age (odds ratio, 1.05;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001) and FPC group assignment (odds ratio, 1.57;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001; relative to PGV+\/FPC\u2013) were independent predictors of harboring a pancreatic cyst.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    PRECEDE provides infrastructure support to increase access to clinical surveillance for HRIs worldwide, while aiming to drive early PC detection advancements through longitudinal standardized clinical data, imaging, and biospecimen captures. Increased cyst prevalence in HRIs with FPC suggests that FPC may infer distinct biological processes. To enable the development of PC surveillance approaches better tailored to risk category, we recommend adoption of subclassification of HRIs into FPC, PGV+\/FPC+, and PGV+\/FPC\u2013 risk groups by surveillance protocols.\n                  <\/jats:p>","DOI":"10.6004\/jnccn.2023.7097","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T16:12:03Z","timestamp":1713283923000},"page":"158-166","source":"Crossref","is-referenced-by-count":32,"title":["The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals"],"prefix":"10.6004","volume":"22","author":[{"given":"George","family":"Zogopoulos","sequence":"first","affiliation":[{"name":"McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Haimi","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenin A.","family":"Sanoba","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Everett","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryson W.","family":"Katona","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Farrell","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Grossberg","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Paiella","sequence":"additional","affiliation":[{"name":"General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey A.","family":"Klute","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bi","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Michigan Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Stoffel","sequence":"additional","affiliation":[{"name":"Michigan Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Wadlow","sequence":"additional","affiliation":[{"name":"Inova Schar Cancer Institute, Fairfax, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Sussman","sequence":"additional","affiliation":[{"name":"University of Miami Health System, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun B.","family":"Merchant","sequence":"additional","affiliation":[{"name":"University of Miami Health System, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Permuth","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Golan","sequence":"additional","affiliation":[{"name":"Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Raitses-Gurevich","sequence":"additional","affiliation":[{"name":"Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[{"name":"UC San Diego Health, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Liau","sequence":"additional","affiliation":[{"name":"UC San Diego Health, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Jeter","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Lindberg","sequence":"additional","affiliation":[{"name":"UMass Memorial Health, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Chung","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Earl","sequence":"additional","affiliation":[{"name":"Ram\u00f3n y Cajal Health Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Brentnall","sequence":"additional","affiliation":[{"name":"University of Washington Medical Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasmintan A.","family":"Schrader","sequence":"additional","affiliation":[{"name":"BC Cancer, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kaul","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchan","family":"Huang","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hersh","family":"Chandarana","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Smerdon","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Graff","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay","family":"Kastrinos","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center\/Herbert Irving Comprehensive Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Kupfer","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee L.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie C.","family":"Sears","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall E.","family":"Brand","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Simeone","sequence":"additional","affiliation":[{"name":"New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"_","family":"_","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Int J Cancer","first-page":"993","article-title":"Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039","volume":"149","author":"Yu J","year":"2021","unstructured":"Yu J, Yang X, He W,  Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Int J Cancer 2021;149:993\u20131001."},{"key":"B2","series-title":"Lancet Gastroenterol Hepatol","first-page":"934","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"4","year":"2019","unstructured":"Pourshams A, Sepanlou SG, Ikuta KS, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019;4:934\u2013947."},{"key":"B3","series-title":"CA Cancer J Clin","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS,  Cancer statistics, 2023. CA Cancer J Clin 2023;73:17\u201348."},{"key":"B4","series-title":"N Engl J Med","first-page":"1039","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan DP","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med 2014;371:1039\u20131049."},{"key":"B5","series-title":"J Natl Cancer Inst","first-page":"1162","article-title":"Recent trends in the incidence and survival of stage 1A pancreatic cancer: a Surveillance, Epidemiology, and End Results analysis","volume":"112","author":"Blackford AL","year":"2020","unstructured":"Blackford AL, Canto MI, Klein AP,  Recent trends in the incidence and survival of stage 1A pancreatic cancer: a Surveillance, Epidemiology, and End Results analysis. J Natl Cancer Inst 2020;112:1162\u20131169."},{"key":"B6","series-title":"JAMA","first-page":"438","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","author":"Owens DK","year":"2019","unstructured":"Owens DK, Davidson KW, Krist AH,  Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement. JAMA 2019;322:438\u2013444."},{"key":"B7","series-title":"Gastroenterology","first-page":"772","article-title":"Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals","volume":"162","author":"Overbeek KA","year":"2022","unstructured":"Overbeek KA, Goggins MG, Dbouk M,  Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals. Gastroenterology 2022;162:772\u2013785.e4."},{"key":"B8","series-title":"J Natl Compr Canc Netw","first-page":"663","article-title":"Is biannual surveillance for pancreatic cancer sufficient in individuals with genetic syndromes or familial pancreatic cancer?","volume":"20","author":"Wang Y","year":"2022","unstructured":"Wang Y, Cuggia A, Chen YI,  Is biannual surveillance for pancreatic cancer sufficient in individuals with genetic syndromes or familial pancreatic cancer? J Natl Compr Canc Netw 2022;20:663\u2013673.e12."},{"key":"B9","series-title":"Pancreas","first-page":"28","article-title":"Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer","volume":"46","author":"Konings ICAW","year":"2017","unstructured":"Konings ICAW, Harinck F, Poley JW,  Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer. Pancreas 2017;46:28\u201334."},{"key":"B10","series-title":"Gut","first-page":"1152","article-title":"Long-term yield of pancreatic cancer surveillance in high-risk individuals","volume":"71","author":"Overbeek KA","year":"2022","unstructured":"Overbeek KA, Levink IJM, Koopmann BDM,  Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 2022;71:1152\u20131160."},{"key":"B11","series-title":"Gastroenterology","first-page":"786","article-title":"Late-stage pancreatic cancer detected during high-risk individual surveillance: a systematic review and meta-analysis","volume":"162","author":"Chhoda A","year":"2022","unstructured":"Chhoda A, Vodusek Z, Wattamwar K,  Late-stage pancreatic cancer detected during high-risk individual surveillance: a systematic review and meta-analysis. Gastroenterology 2022;162:786\u2013798."},{"key":"B12","series-title":"J Clin Oncol","first-page":"3267","article-title":"Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up","volume":"40","author":"Klatte DCF","year":"2022","unstructured":"Klatte DCF, Boekestijn B, Wasser MN,  Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J Clin Oncol 2022;40:3267\u20133277."},{"key":"B13","series-title":"J Clin Oncol","first-page":"3257","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk M","year":"2022","unstructured":"Dbouk M, Katona BW, Brand RE,  The multicenter cancer of pancreas screening study: impact on stage and survival. J Clin Oncol 2022;40:3257\u20133266."},{"key":"B14","series-title":"Gastroenterology","first-page":"1223","article-title":"Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: a propensity score-matched analysis","volume":"164","author":"Klatte DCF","year":"2023","unstructured":"Klatte DCF, Boekestijn B, Onnekink AM,  Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: a propensity score-matched analysis. Gastroenterology 2023;164:1223\u20131231.e4."},{"key":"B15","series-title":"Gut","first-page":"7","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins M","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand RE,  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020;69:7\u201317."},{"key":"B16","series-title":"Gastroenterology","first-page":"358","article-title":"AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review","volume":"159","author":"Aslanian HR","year":"2020","unstructured":"Aslanian HR, Lee JH, Canto MI. AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology 2020;159:358\u2013362."},{"key":"B17","series-title":"Gastrointest Endosc","first-page":"817","article-title":"ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations","volume":"95","author":"Sawhney MS","year":"2022","unstructured":"Sawhney MS, Calderwood AH, Thosani NC,  ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 2022;95:817\u2013826."},{"key":"B18","series-title":"J Cancer Educ","first-page":"194","article-title":"Health care provider perceptions of caring for individuals with inherited pancreatic cancer risk","volume":"35","author":"Underhill ML","year":"2020","unstructured":"Underhill ML, Pozzar R, Chung D,  Health care provider perceptions of caring for individuals with inherited pancreatic cancer risk. J Cancer Educ 2020;35:194\u2013203."},{"key":"B19","series-title":"J Clin Oncol","first-page":"e16239","article-title":"The PRECEDE consortium: a longitudinal international cohort study of individuals with genetic risk or familial pancreatic cancer","volume":"40","author":"Zogopoulos G","year":"2022","unstructured":"Zogopoulos G, Bi Y, Brand RE,  The PRECEDE consortium: a longitudinal international cohort study of individuals with genetic risk or familial pancreatic cancer. J Clin Oncol 2022;40(Suppl):Abstract e16239."},{"key":"B20","series-title":"Gastroenterology","first-page":"1751","article-title":"Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (Pancreatic Cancer Early Detection) Consortium","volume":"161","author":"Gonda TA","year":"2021","unstructured":"Gonda TA, Everett JN, Wallace M,  Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (Pancreatic Cancer Early Detection) Consortium. Gastroenterology 2021;161:1751\u20131757."},{"key":"B21","series-title":"Gastrointest Endosc","first-page":"723","article-title":"Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium","volume":"95","author":"Gonda TA","year":"2022","unstructured":"Gonda TA, Farrell J, Wallace M,  Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium. Gastrointest Endosc 2022;95:723\u2013732.e7."},{"key":"B22","series-title":"AJR Am J Roentgenol","first-page":"903","article-title":"Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE Consortium","volume":"219","author":"Huang C","year":"2022","unstructured":"Huang C, Simeone DM, Luk L,  Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE Consortium. AJR Am J Roentgenol 2022;219:903\u2013914."},{"key":"B23","series-title":"J Clin Oncol","first-page":"1070","article-title":"Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance","volume":"37","author":"Abe T","year":"2019","unstructured":"Abe T, Blackford AL, Tamura K,  Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance. J Clin Oncol 2019;37:1070\u20131080."},{"key":"B24","series-title":"Gastroenterology","first-page":"1447","article-title":"Very high risk of cancer in familial Peutz-Jeghers syndrome","volume":"119","author":"Giardiello FM","year":"2000","unstructured":"Giardiello FM, Brensinger JD, Tersmette AC,  Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447\u20131453."},{"key":"B25","series-title":"Pancreatology","first-page":"613","article-title":"Guidelines on management of pancreatic cysts detected in high-risk individuals: an evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) Consortium statements","volume":"21","author":"Dbouk M","year":"2021","unstructured":"Dbouk M, Brewer Gutierrez OI, Lennon AM,  Guidelines on management of pancreatic cysts detected in high-risk individuals: an evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) Consortium statements. Pancreatology 2021;21:613\u2013621."},{"key":"B26","series-title":"Nature","first-page":"378","article-title":"A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns","volume":"538","author":"Notta F","year":"2016","unstructured":"Notta F, Chan-Seng-Yue M, Lemire M,  A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 2016;538:378\u2013382."},{"key":"B27","series-title":"Nature","first-page":"1114","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida S","year":"2010","unstructured":"Yachida S, Jones S, Bozic I,  Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114\u20131117."},{"key":"B28","series-title":"Ann Surg","first-page":"e384","article-title":"Serine\/threonine kinase 11 plays a canonical role in malignant progression of KRAS -mutant and GNAS -wild-type intraductal papillary mucinous neoplasms of the pancreas","volume":"277","author":"Omori Y","year":"2023","unstructured":"Omori Y, Ono Y, Morikawa T,  Serine\/threonine kinase 11 plays a canonical role in malignant progression of KRAS -mutant and GNAS -wild-type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2023;277:e384\u2013395."},{"key":"B29","series-title":"Am J Pathol","first-page":"2017","article-title":"STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas","volume":"159","author":"Sato N","year":"2001","unstructured":"Sato N, Rosty C, Jansen M,  STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001;159:2017\u20132022."},{"key":"B30","series-title":"Pancreatology","first-page":"738","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka M","year":"2017","unstructured":"Tanaka M, Fern\u00e1ndez-del Castillo C, Kamisawa T,  Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738\u2013753."},{"key":"B31","series-title":"Gastroenterology","first-page":"117","article-title":"Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts","volume":"164","author":"Paniccia A","year":"2023","unstructured":"Paniccia A, Polanco PM, Boone BA,  Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts. Gastroenterology 2023;164:117\u2013133.e7."},{"key":"B32","series-title":"Gastroenterology","first-page":"740","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto MI","year":"2018","unstructured":"Canto MI, Almario JA, Schulick RD,  Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology 2018;155:740\u2013751.e2."},{"key":"B33","series-title":"Cancer Prev Res (Phila)","first-page":"343","article-title":"Racial, ethnic, and sex-based disparities among high-risk individuals undergoing pancreatic cancer surveillance","volume":"16","author":"Katona BW","year":"2023","unstructured":"Katona BW, Klute K, Brand RE,  Racial, ethnic, and sex-based disparities among high-risk individuals undergoing pancreatic cancer surveillance. Cancer Prev Res (Phila) 2023;16:343\u2013352."},{"key":"B34","series-title":"Dev Psychol","first-page":"1993","article-title":"Discrimination, segregation, and chronic inflammation: testing the weathering explanation for the poor health of Black Americans","volume":"54","author":"Simons RL","year":"2018","unstructured":"Simons RL, Lei MK, Beach SR,  Discrimination, segregation, and chronic inflammation: testing the weathering explanation for the poor health of Black Americans. Dev Psychol 2018;54:1993\u20132006."},{"key":"B35","series-title":"Health Serv Res","first-page":"1374","article-title":"Understanding how discrimination can affect health","volume":"54","author":"Williams DR","year":"2019","unstructured":"Williams DR, Lawrence JA, Davis BA,  Understanding how discrimination can affect health. Health Serv Res 2019;54(Suppl 2):1374\u20131388."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/22\/3\/article-p158.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/22\/3\/article-p158.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/22\/3\/article-p158.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T16:12:03Z","timestamp":1713283923000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/22\/3\/article-p158.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2023.7097","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}